LungLife AI, Inc.
LLAI.L · LSE
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | £0 | £0 | £0 | £0 |
| - Cash | £0 | £0 | £0 | £0 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | £0 | £0 | £0 | £0 |
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | 91.7% | -87.7% | -4.7% | – |
| Gross Profit | £0 | £0 | £0 | £0 |
| % Margin | 100% | 100% | 50.8% | 8.3% |
| EBITDA | -£0 | -£0 | -£0 | -£0 |
| % Margin | -11,110.9% | -30,270.8% | -3,419.8% | -1,841.9% |
| Net Income | -£0 | -£0 | -£0 | -£0 |
| % Margin | -11,767.4% | -31,691.7% | -3,806.5% | -2,737.2% |
| EPS Diluted | -0.21 | -0.3 | -0.47 | -0.22 |
| % Growth | 30% | 36.2% | -113.6% | – |
| Operating Cash Flow | -£0 | -£0 | -£0 | -£0 |
| Capital Expenditures | -£0 | -£0 | -£0 | -£0 |
| Free Cash Flow | -£0 | -£0 | -£0 | -£0 |